Nu Skin Enterprises, INC 8-K filings

Nu Skin Enterprises announced a significant year-over-year revenue decrease of 17.1% for the second quarter of 2026, alongside a substantial net loss and a large impairment charge.

Nu Skin Enterprises stockholders approved an amended incentive plan, increasing share authorization by 2.85 million shares and extending the plan's term to 2036.

Nu Skin Enterprises reported Q1 2026 revenue of $320.6 million, meeting guidance while navigating a challenging global environment.

Nu Skin Enterprises, Inc. has entered into a new $250 million senior secured credit facility, comprising a $175 million term loan and a $75 million revolving credit facility, to refinance existing debt and support general corporate purposes.

Nu Skin Enterprises announced the resignation of CFO James Thomas and the immediate appointment of Chelsea Lantz as interim Chief Financial Officer.

Nu Skin Enterprises reported fourth quarter and full-year 2025 financial results within guidance, with over 50% growth in adjusted earnings for 2025, and provided an initial outlook for 2026, anticipating a return to revenue growth by year-end.

Nu Skin Enterprises reported third-quarter revenue and earnings per share within its guidance range, with EPS at the high end, as it prepares for the launch of its Prysm iO intelligent wellness platform and expansion into India.

Nu Skin Enterprises reported second-quarter 2025 revenue at the high end of guidance and earnings per share exceeding forecasts, driven by strong operating margin and cash position.

Nu Skin Enterprises, Inc. stockholders have approved the Amended and Restated 2024 Omnibus Incentive Plan, increasing the share reserve by 790,000 shares and extending its term to 2035, alongside the election of nine directors and ratification of executive compensation and auditors.

Nu Skin Enterprises announced first quarter revenue at the high end of its guidance range, with revenue reaching $364.5 million.

Zheqing (Simon) Shen will not seek re-election to Nu Skin's Board of Directors due to other professional commitments.

Nu Skin Enterprises announced Q4 and full-year 2024 financial results exceeding revenue guidance, with a focus on strengthening the core business and accelerating growth in developing markets in 2025.

Nu Skin Enterprises reports Q4 2024 preliminary revenue at the high end of its guidance range.

Nu Skin Enterprises has divested its Mavely affiliate marketing technology platform to Later for approximately $250 million in cash and a minority equity stake.

Nu Skin Enterprises announced third-quarter results that met previous guidance, with core business challenges partially offset by strong growth in the Rhyz segment, while also adjusting their full-year outlook due to ongoing pressures.

Nu Skin Enterprises has amended its bylaws to update procedures for stockholder nominations and proposals at meetings, effective October 31, 2024.

Nu Skin Enterprises has appointed Mark A. Zorko as a new director, increasing the board size to nine members and assigning him to the Audit and Nominating and Corporate Governance Committees.

Nu Skin Enterprises announced second quarter results in line with revenue guidance, with the Rhyz business growing 32.3% year-over-year, while the core Nu Skin business navigates macroeconomic challenges.

Nu Skin Enterprises' stockholders approved the 2024 Omnibus Incentive Plan, which replaces the 2010 plan and provides for various equity-based awards to employees, directors, and consultants.

Nu Skin Enterprises announced first quarter results that met guidance, with revenue of $417.3 million and a significant 57.5% year-over-year growth in its Rhyz business, despite challenges in the core Nu Skin business.

Andrew Lipman will retire from Nu Skin Enterprises' Board of Directors and will not seek re-election at the 2024 Annual Meeting of Stockholders.

Nu Skin Enterprises announced fourth quarter and full-year 2023 results slightly above its latest guidance, while also updating capital allocation priorities and providing an initial outlook for 2024.

Nu Skin Enterprises updated its bylaws to conform with Delaware law, clarify meeting procedures, and revise requirements for stockholder nominations and proposals.